Free cash flow margins exhibit significant lumpiness, ranging from 7.3% to 29.3%, though operating cash flow consistently outpaces net income with an OCF/NI ratio as high as 2.74.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Cash from Operations | 2.7B | 2.65B | 2.72B | 2.15B | 2.26B | 2.94B | 1.96B | 1.42B | 1.25B | 970M | 860M | 475.69M | 431.75M | 397.37M | 335.7M | 160.95M |
| Operating CF Margin % | - | 16.27% | 17.63% | 14.34% | 15.68% | 21.21% | 17.25% | 12.78% | 12.04% | 10% | 12.62% | 8.29% | 7.91% | 7.79% | 6.9% | 3.72% |
| Operating CF Growth % | -6.87% | -2.28% | 26.38% | -4.91% | -23.18% | 50.18% | 38.25% | 13% | 29.28% | 12.79% | 80.79% | 10.18% | 8.65% | 18.37% | 108.57% | - |
| Net Income | 1.39B | 1.36B | 1.37B | 1.36B | 1.09B | 966M | 308M | 227M | 284M | 1.33B | 130M | 388.3M | 356.5M | 226.03M | 176.63M | 240.33M |
| Depreciation & Amortization | 1.17B | 1.14B | 1.11B | 1.13B | 1.13B | 1.26B | 1.29B | 1.2B | 1.14B | 1.01B | 289M | 127.74M | 121.01M | 107.5M | 98.29M | 92M |
| Stock-Based Compensation | 180M | 247M | 206M | 217M | 194M | 170M | 95M | 146M | 113M | 106M | 80M | 37.76M | 30M | 22.83M | 25.93M | 14.13M |
| Deferred Taxes | -177M | -180M | -129M | -269M | -115M | -138M | -176M | -157M | -177M | -1.22B | 135M | 18.35M | -6.17M | -24.24M | 16.59M | -73.22M |
| Other Non-Cash Items | -166M | -43M | -6M | -2M | 44M | 0 | -14M | -20M | -1M | 33M | 14M | -27.5M | -23.73M | 5.47M | 5.8M | -29.75M |
| Working Capital Changes | 313M | 125M | 158M | -280M | -84M | 680M | 459M | 19M | -106M | -292M | 212M | -68.97M | -45.86M | 59.78M | 12.46M | -82.55M |
| Change in Receivables | 125M | 60M | 182M | -388M | -421M | -138M | 255M | -124M | -297M | -142M | -62M | -246.03M | -78.63M | -151.68M | -60.26M | -115.75M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116M | -184M | -136M | 62M | 18.87M | -32.98M | 32.56M | -40.13M | 18.24M |
| Change in Payables | 0 | -96M | 115M | 267M | 427M | 244M | 253M | 240M | 368M | 90M | 160M | 104.35M | 45.8M | 107.05M | 58.34M | 67.38M |
| Cash from Investing | -2.2B | -2.31B | -1.44B | -1.6B | -2.01B | -2.1B | -796M | -1.19B | -810M | -1.19B | 1.73B | -66.95M | -173.11M | -240.18M | -132.23M | -224.84M |
| Capital Expenditures | -32M | 0 | -602M | -649M | -674M | -640M | -616M | -582M | -459M | -369M | -164M | -78.39M | -82.65M | -92.35M | -71.34M | -75.68M |
| CapEx % of Revenue | 0.19% | 3.7% | 3.91% | 4.33% | 4.68% | 4.61% | 5.42% | 5.25% | 4.41% | 3.8% | 2.41% | 1.37% | 1.51% | 1.81% | 1.47% | 1.75% |
| Acquisitions | -1.6B | -1.71B | -710M | -876M | -1.33B | -1.46B | -167M | -588M | -326M | -827M | 1.87B | 19.38M | -96.67M | -149.99M | -47.42M | -135.82M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -540M | -573M | 2M | 5M | 8M | 0 | -2M | 27M | -457M | 2M | 24M | 551K | -1.26M | 138K | -182K | 16.37M |
| Cash from Financing | -325M | -150M | -878M | -382M | -329M | -1.24B | -217M | -276M | -452M | -72M | -2.28B | -249.25M | -130.34M | 70.96M | -146.87M | -59.31M |
| Debt Issued (Net) | 1.24B | 1.21B | 553M | 802M | 941M | 70M | 342M | 747M | 1.01B | 2.51B | -1.31B | 188M | 242M | -387.66M | 440.14M | 260.12M |
| Equity Issued (Net) | -456M | -1.31B | -1.35B | -992M | -1.17B | -406M | -447M | -949M | -1.41B | -2.62B | -1.1B | -515M | -415M | -6.43M | -10.25M | -14.32M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -567.85M | -288.32M |
| Share Repurchases | -389M | -1.24B | -1.35B | -992M | -1.17B | -406M | -447M | -949M | -1.41B | -2.62B | -1.1B | -515.01M | -415M | -6.43M | -13.36M | -14.32M |
| Other Financing | -1.11B | -44M | -81M | -192M | -102M | -899M | -112M | -74M | -62M | 37M | 126M | 77.75M | 42.66M | 465.05M | -8.91M | -16.78M |
| Net Change in Cash | 207M | 278M | 326M | 160M | -150M | -448M | 977M | -54M | -68M | -239M | 221M | 109.79M | 89.22M | 210.41M | 51.43M | -130.32M |
| Free Cash Flow | 2.67B | 2.05B | 2.11B | 1.5B | 1.59B | 2.3B | 1.34B | 835M | 795M | 601M | 696M | 397.3M | 349.1M | 305.02M | 264.37M | 85.27M |
| FCF Margin % | 16.07% | 12.58% | 13.72% | 10.01% | 11.01% | 16.59% | 11.82% | 7.53% | 7.64% | 6.19% | 10.21% | 6.93% | 6.39% | 5.98% | 5.43% | 1.97% |
| FCF Growth % | 23.53% | -2.98% | 40.93% | -5.42% | -31.1% | 71.41% | 60.84% | 5.03% | 32.28% | -13.65% | 75.18% | 13.81% | 14.45% | 15.38% | 210.02% | - |
| FCF per Share | 15.74 | 11.82 | 11.53 | 8.05 | 8.32 | 11.81 | 6.89 | 4.18 | 3.82 | 2.70 | 4.58 | 3.16 | 2.66 | 2.39 | 2.07 | 0.67 |
| FCF Conversion (FCF/Net Income) | 1.93x | 1.95x | 1.98x | 1.58x | 2.07x | 3.05x | 7.02x | 7.42x | 4.84x | 0.74x | 7.48x | 1.23x | 1.21x | 1.75x | 1.89x | 0.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 398M | 320M | 124M | 82M | 94M | 115.49M | 127.13M | 100.91M |
| Taxes Paid | 0 | 0 | 295M | 340M | 255M | 222M | 0 | 0 | 211M | 195M | 106M | 121M | 139M | 70.98M | 103.98M | 63.37M |
Clinical trial backlog volatility
As reported in financial statements, IQVIA consistently generates operating cash flow significantly higher than net income, with the OCF/NI ratio reaching as high as 2.74 in 2025Q3, suggesting that non-cash charges like amortization of intangibles play a substantial role in the company's reported GAAP profitability.
The persistent gap between net income and operating cash flow indicates that the company's accounting earnings are heavily impacted by non-cash expenses, likely stemming from the amortization of assets acquired during its aggressive M&A history. Investors should monitor this divergence, as it suggests that cash-generating power is more robust than the bottom-line GAAP figures imply.
Based on the provided quarterly data, IQVIA's free cash flow margins have fluctuated significantly, ranging from a low of 7.3% in 2025Q2 to a peak of 29.3% in 2025Q3, reflecting the inherent lumpiness of project-based clinical trial milestones and the timing of large-scale capital expenditures.
The inconsistency in FCF margins suggests that the company's ability to convert revenue into cash is highly sensitive to the timing of contract completions and the associated working capital swings. This volatility makes it difficult to project long-term cash flow stability, necessitating a cautious approach when evaluating the company's ability to fund future growth internally.
According to recent SEC filings, IQVIA's capital expenditure as a percentage of revenue has remained relatively stable, generally hovering between 3.7% and 4.6% over the last ten quarters, which indicates that the business model does not require massive, recurring physical asset investment to maintain its current operations.
The relatively low capital intensity suggests that the company's primary investments are directed toward software development and data infrastructure rather than heavy machinery or physical facilities. While this supports a more asset-light model, investors should investigate whether this level of spending is sufficient to maintain the competitive edge of its proprietary data platforms against evolving technological threats.
As evidenced by the quarterly cash flow statements, IQVIA has prioritized share repurchases over other forms of capital return, with a notable $1.1 billion outflow in 2024Q4, while simultaneously maintaining a consistent pace of net acquisitions to bolster its integrated service and data offerings.
The company's reliance on share buybacks as a primary capital deployment tool suggests a management focus on offsetting dilution or supporting the share price, rather than returning cash to shareholders via dividends. This strategy warrants further investigation into whether these repurchases are providing adequate returns on invested capital compared to potential organic growth opportunities.
Quick answers to the most common questions about buying IQV stock.
IQVIA Holdings Inc. (IQV) generated $2.65B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
IQVIA Holdings Inc. (IQV) generated $2.05B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
IQVIA Holdings Inc. (IQV) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, IQVIA Holdings Inc. (IQV) spent $1.24B on share repurchases. This shows the company's commitment to returning capital to its equity investors.